Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children, 80573-80574 [2024-22733]

Download as PDF ddrumheller on DSK120RN23PROD with NOTICES1 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices representatives of WTC responders as well as representatives of certifiedeligible WTC survivors. DATES: Nominations for membership on the STAC must be received no later than November 11, 2024. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to NIOSH Docket 229–L, c/o Mia Wallace, Committee Management Specialist, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–4, Atlanta, Georgia 30329–4027, or emailed to nioshdocket@cdc.gov. FOR FURTHER INFORMATION CONTACT: Tania Carreón-Valencia, Ph.D., M.S., Designated Federal Officer, World Trade Center Health Program Scientific/ Technical Advisory Committee, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop R–12, Atlanta, Georgia 30329–4027. Telephone: (513) 841–4515 (this is not a toll-free number); Email: TCarreonValencia@cdc.gov. SUPPLEMENTARY INFORMATION: The World Trade Center (WTC) Health Program Scientific/Technical Advisory Committee (STAC) reviews scientific and medical evidence and makes recommendations to the Administrator of the WTC Health Program on additional Program eligibility criteria and, upon request, additional WTCrelated health conditions, reviews and evaluates policies and procedures used to determine whether sufficient evidence exists to support adding a health condition to the List of WTCRelated Health Conditions (List), makes recommendations regarding individuals to conduct independent peer reviews of the scientific and technical evidence underlying a final rule adding a condition to the List, and provides consultation on research regarding certain health conditions related to the September 11, 2001, terrorist attacks. Nominations are sought for individuals with the expertise and qualifications necessary to accomplish the Committee’s objectives. The Administrator of the WTC Health Program is seeking nominations for members fulfilling the following categories: • Two occupational physicians, one of whom should have experience treating WTC rescue and recovery workers; • Environmental medicine/ environmental health professional; • Toxicologist; • Epidemiologist; VerDate Sep<11>2014 17:59 Oct 02, 2024 Jkt 265001 • Representative of WTC responders; and • Representative of certified-eligible WTC survivors. Members may be invited to serve for four-year terms. Selection of members is based on candidates’ qualifications to contribute to accomplishing STAC objectives. More information on the Committee is available at https:// www.cdc.gov/wtc/stac.html. Department of Health and Human Services (HHS) policy stipulates that committee membership be balanced in terms of points of view represented and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens. Current participation on Federal workgroups or prior experience serving on a Federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning of and annually during their terms. NIOSH identifies potential candidates and provides a slate of nominees for consideration to the Director of the Centers for Disease Control and Prevention (CDC) for STAC membership each year; CDC reviews the proposed slate of candidates and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in October, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. Candidates should submit the following items: • Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address); • The category of membership (environmental medicine or environmental health specialist, occupational physician, pulmonary physician, representative of WTC responders, certified-eligible WTC survivor representative, industrial hygienist, toxicologist, epidemiologist, or mental health professional) that the candidate is qualified to represent; • A summary of the background, experience, and qualifications that PO 00000 Frm 00122 Fmt 4703 Sfmt 4703 80573 demonstrates the candidate’s suitability for the nominated membership category along with an indication of whether the candidate is currently enrolled in the WTC Health Program; and • At least one letter of recommendation from person(s) not employed by HHS. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., CDC, National Institutes of Health, Food and Drug Administration). Nominations may be submitted by the candidate or by the person/organization recommending the candidate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–22866 Filed 10–2–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC or Committee) has scheduled a public meeting. Information about ACHDNC and the agenda for this meeting can be found on the ACHDNC website at https://www.hrsa.gov/advisorycommittees/heritable-disorders/ index.html. DATES: Thursday, November 14, 2024, from 10 a.m. to 4 p.m. eastern time (ET). ADDRESSES: This meeting will be held via webinar. While this meeting is open to the public, advance registration is SUMMARY: E:\FR\FM\03OCN1.SGM 03OCN1 ddrumheller on DSK120RN23PROD with NOTICES1 80574 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices required. Please visit the ACHDNC website for information on registration: https://www.hrsa.gov/advisorycommittees/heritable-disorders/ index.html. Register no later than 12:00 p.m. ET on November 13, 2024. Instructions on how to access the meeting via webcast will be provided upon registration. FOR FURTHER INFORMATION CONTACT: Leticia Manning, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, Room, Rockville, Maryland 20857; 301–443–8335; or ACHDNC@hrsa.gov. SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations to the Secretary of Health and Human Services (Secretary) on the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. ACHDNC reviews and reports regularly on newborn and childhood screening practices, recommends improvements in the national newborn and childhood screening programs, and fulfills requirements stated in the authorizing legislation. In addition, ACHDNC’s recommendations regarding inclusion of additional conditions for screening on the Recommended Uniform Screening Panel, following adoption by the Secretary, are evidence-informed preventive health services provided for in the comprehensive guidelines supported by HRSA pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 300gg–13). Under this provision, non-grandfathered group health plans and health insurance issuers offering non-grandfathered group or individual health insurance are required to provide insurance coverage without cost-sharing (a co-payment, coinsurance, or deductible) for preventive services for plan years (i.e., policy years) beginning on or after the date that is 1 year from the Secretary’s adoption of the condition for screening. During the November 14, 2024, meeting, ACHDNC will hear from experts in the fields of public health, medicine, heritable disorders, rare disorders, and newborn screening. Possible agenda items may include the following topics: (1) An update on the development of a newborn screening family outcomes tool, (2) A panel presentation on funding opportunities for research that includes the lived experience, (3) A presentation on the Newborn Screening Information Center, and VerDate Sep<11>2014 17:59 Oct 02, 2024 Jkt 265001 (4) An update on Recommended Uniform Screening Panel condition nomination submissions. Agenda items are subject to change as priorities dictate. Information about ACHDNC, including a roster of members and past meeting summaries, is available on the ACHDNC website listed above. Members of the public will have the opportunity to provide comments on any of the above agenda items. Public participants may request to provide general oral comments and may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to provide a written statement or make oral comments to ACHDNC must be submitted via the registration website by 12:00 p.m. ET on Thursday, October 31, 2024. Written comments will be shared with the Committee prior to the meeting so they have an opportunity to consider them in advance of the meeting. Individuals who need special assistance or another reasonable accommodation should notify Leticia Manning at the address and phone number listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2024–22733 Filed 10–2–24; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Charter Renewal of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the charter for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) has been renewed. FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated Federal Officer, Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, SUMMARY: PO 00000 Frm 00123 Fmt 4703 Sfmt 4703 Rockville, MD 20852. Phone: 202–746– 1512; Email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), established by Executive Order 13676, is continued by section 505 of Public Law 116–22, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92– 463, as amended (5 U.S.C. app.), which sets forth standards for the formation and use of Federal advisory committees. FACA stipulates that the charter for a Federal advisory committee must be renewed every two years. The PACCARB shall advise and provide information and recommendations to the Secretary of Health and Human Services (Secretary) regarding programs and policies intended to reduce or combat antibioticresistant bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. The PACCARB shall function solely for advisory purposes. Such advice, information, and recommendations may be related to improving: the effectiveness of antibiotics; research and advanced research on, and the development of, improved and innovative methods for combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities; surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics; education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals; methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections; including stewardship programs; and coordination with respect to international efforts in order to inform and advance the United States capabilities to combat antibiotic resistance. On August 29, 2024, the Secretary of Health and Human Services approved the renewal of the PACCARB’s charter. The new charter was executed and filed with the appropriate Congressional committees and the Library of Congress on August 29, 2024. The renewal of the E:\FR\FM\03OCN1.SGM 03OCN1

Agencies

[Federal Register Volume 89, Number 192 (Thursday, October 3, 2024)]
[Notices]
[Pages 80573-80574]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22733]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Heritable Disorders in 
Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Heritable Disorders in 
Newborns and Children (ACHDNC or Committee) has scheduled a public 
meeting. Information about ACHDNC and the agenda for this meeting can 
be found on the ACHDNC website at https://www.hrsa.gov/advisory-committees/heritable-disorders/.

DATES: Thursday, November 14, 2024, from 10 a.m. to 4 p.m. eastern time 
(ET).

ADDRESSES: This meeting will be held via webinar. While this meeting is 
open to the public, advance registration is

[[Page 80574]]

required. Please visit the ACHDNC website for information on 
registration: https://www.hrsa.gov/advisory-committees/heritable-disorders/. Register no later than 12:00 p.m. ET on November 
13, 2024. Instructions on how to access the meeting via webcast will be 
provided upon registration.

FOR FURTHER INFORMATION CONTACT: Leticia Manning, Maternal and Child 
Health Bureau, HRSA, 5600 Fishers Lane, Room, Rockville, Maryland 
20857; 301-443-8335; or [email protected].

SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations 
to the Secretary of Health and Human Services (Secretary) on the 
development of newborn screening activities, technologies, policies, 
guidelines, and programs for effectively reducing morbidity and 
mortality in newborns and children having, or at risk for, heritable 
disorders. ACHDNC reviews and reports regularly on newborn and 
childhood screening practices, recommends improvements in the national 
newborn and childhood screening programs, and fulfills requirements 
stated in the authorizing legislation. In addition, ACHDNC's 
recommendations regarding inclusion of additional conditions for 
screening on the Recommended Uniform Screening Panel, following 
adoption by the Secretary, are evidence-informed preventive health 
services provided for in the comprehensive guidelines supported by HRSA 
pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 
300gg-13). Under this provision, non-grandfathered group health plans 
and health insurance issuers offering non-grandfathered group or 
individual health insurance are required to provide insurance coverage 
without cost-sharing (a co-payment, co-insurance, or deductible) for 
preventive services for plan years (i.e., policy years) beginning on or 
after the date that is 1 year from the Secretary's adoption of the 
condition for screening.
    During the November 14, 2024, meeting, ACHDNC will hear from 
experts in the fields of public health, medicine, heritable disorders, 
rare disorders, and newborn screening. Possible agenda items may 
include the following topics:
    (1) An update on the development of a newborn screening family 
outcomes tool,
    (2) A panel presentation on funding opportunities for research that 
includes the lived experience,
    (3) A presentation on the Newborn Screening Information Center, and
    (4) An update on Recommended Uniform Screening Panel condition 
nomination submissions.
    Agenda items are subject to change as priorities dictate. 
Information about ACHDNC, including a roster of members and past 
meeting summaries, is available on the ACHDNC website listed above.
    Members of the public will have the opportunity to provide comments 
on any of the above agenda items. Public participants may request to 
provide general oral comments and may submit written statements in 
advance of the scheduled meeting. Oral comments will be honored in the 
order they are requested and may be limited as time allows. Requests to 
provide a written statement or make oral comments to ACHDNC must be 
submitted via the registration website by 12:00 p.m. ET on Thursday, 
October 31, 2024. Written comments will be shared with the Committee 
prior to the meeting so they have an opportunity to consider them in 
advance of the meeting.
    Individuals who need special assistance or another reasonable 
accommodation should notify Leticia Manning at the address and phone 
number listed above at least 10 business days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-22733 Filed 10-2-24; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.